|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 212.26 USD | -0.88% |
|
+0.37% | +8.72% |
| 16/07 | CPC Biotech, Part of PSG and Dover Launches RevolveSD Series One-Inch Single-Use Sterile Disconnect for Bioprocessing | CI |
| 10/07 | Goldman Sachs Adjusts Price Target on Dover to $255 From $263 | MT |
Company Valuation: Dover Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,148 | 19,005 | 21,517 | 25,737 | 26,778 | 28,583 | - | - |
| Change | - | -27.32% | 13.21% | 19.62% | 4.04% | 6.74% | - | - |
| Enterprise Value (EV) 1 | 28,887 | 22,303 | 24,561 | 26,822 | 28,429 | 29,699 | 29,015 | 28,486 |
| Change | - | -22.79% | 10.12% | 9.21% | 5.99% | 4.47% | -2.3% | -1.82% |
| P/E | 23.5x | 18.2x | 20.5x | 9.65x | 24.6x | 23.4x | 20.7x | 19.1x |
| PBR | 6.24x | 4.51x | 4.21x | 3.72x | 3.61x | 3.57x | 3.27x | 3.01x |
| PEG | - | -4.4x | 15.21x | 0x | -0.4x | 1.6x | 1.6x | 2.23x |
| Capitalization / Revenue | 3.31x | 2.23x | 2.55x | 3.32x | 3.31x | 3.3x | 3.16x | 3.02x |
| EV / Revenue | 3.65x | 2.62x | 2.91x | 3.46x | 3.51x | 3.43x | 3.2x | 3.01x |
| EV / EBITDA | 17.9x | 13.5x | 13.9x | 16.1x | 15.3x | 14.8x | 13.5x | 12.5x |
| EV / EBIT | 21.9x | 16.6x | 17.2x | 17.6x | 16.7x | 16.2x | 14.8x | 13.2x |
| EV / FCF | 30.6x | 38.1x | 21.5x | 29.1x | 25.4x | 22.9x | 19.6x | 17.7x |
| FCF Yield | 3.27% | 2.62% | 4.66% | 3.43% | 3.93% | 4.37% | 5.09% | 5.66% |
| Dividend per Share 2 | 1.99 | 2.01 | 2.03 | 2.05 | 2.07 | 2.133 | 2.192 | 2.204 |
| Rate of return | 1.1% | 1.48% | 1.32% | 1.09% | 1.06% | 1% | 1.03% | 1.04% |
| EPS 2 | 7.74 | 7.42 | 7.52 | 19.45 | 7.94 | 9.069 | 10.26 | 11.13 |
| Distribution rate | 25.7% | 27.1% | 27% | 10.5% | 26.1% | 23.5% | 21.4% | 19.8% |
| Net sales 1 | 7,907 | 8,508 | 8,438 | 7,746 | 8,093 | 8,649 | 9,059 | 9,477 |
| EBITDA 1 | 1,610 | 1,648 | 1,765 | 1,670 | 1,861 | 2,006 | 2,150 | 2,279 |
| EBIT 1 | 1,320 | 1,340 | 1,430 | 1,524 | 1,703 | 1,832 | 1,964 | 2,154 |
| Net income 1 | 1,124 | 1,065 | 1,057 | 2,697 | 1,094 | 1,231 | 1,369 | 1,463 |
| Net Debt 1 | 2,739 | 3,297 | 3,044 | 1,085 | 1,651 | 1,116 | 431.4 | -97.41 |
| Reference price 2 | 181.60 | 135.41 | 153.81 | 187.60 | 195.24 | 212.26 | 212.26 | 212.26 |
| Nbr of stocks (in thousands) | 1,43,985 | 1,40,354 | 1,39,890 | 1,37,192 | 1,37,153 | 1,34,661 | - | - |
| Announcement Date | 27/01/22 | 31/01/23 | 01/02/24 | 30/01/25 | 29/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 23.61x | 3.46x | 14.93x | 1% | 2.88TCr | ||
| 35.42x | 6.08x | 22.56x | 0.76% | 12TCr | ||
| 31.97x | 5.93x | 20.49x | 1.89% | 3.94TCr | ||
| 32.99x | 4.23x | 15.61x | 0.11% | 3.09TCr | ||
| 131.02x | 45.34x | 106.3x | 0.29% | 3.08TCr | ||
| 20.59x | 1.7x | 12.48x | 2.36% | 2.93TCr | ||
| 26.59x | 3.19x | 13.91x | 1.42% | 2.89TCr | ||
| 25.09x | 3.94x | 13.23x | 1.45% | 2.82TCr | ||
| 26.13x | 3.38x | 16.15x | 1.74% | 2.42TCr | ||
| 94.45x | 6.48x | 34.12x | - | 2.31TCr | ||
| Average | 44.78x | 8.37x | 26.98x | 1.22% | 3.85TCr | |
| Weighted average by Cap. | 42.05x | 8.01x | 26.12x | 1.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DOV Stock
- Valuation Dover Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















